Hypnotic efficacy of a modified triazolodiazepine, brotizolam

Roberto A. Dominguez, Burton J. Goldstein, Alan F. Jacobson, Richard M. Steinbook

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t 1 2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subjects who were receiving brotizolam were taking 0.50 mg. Results indicate brotizolam efficacy as measured by daily subject and weekly physician questionnaires in essentially all sleep parameters, including global subject and physician evaluation of treatment efficacy, sleep latency and sleep maintenance, and quality of sleep. Tolerance to the hypnotic action of brotizolam was not observed after 21 days of daily dosing.

Original languageEnglish
Pages (from-to)674-679
Number of pages6
JournalClinical Pharmacology and Therapeutics
Volume37
Issue number6
StatePublished - Jun 1 1985
Externally publishedYes

Fingerprint

brotizolam
WEB 2086
Hypnotics and Sedatives
Sleep
Physicians
Sleep Initiation and Maintenance Disorders
Outpatients
Maintenance
Safety

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., & Steinbook, R. M. (1985). Hypnotic efficacy of a modified triazolodiazepine, brotizolam. Clinical Pharmacology and Therapeutics, 37(6), 674-679.

Hypnotic efficacy of a modified triazolodiazepine, brotizolam. / Dominguez, Roberto A.; Goldstein, Burton J.; Jacobson, Alan F.; Steinbook, Richard M.

In: Clinical Pharmacology and Therapeutics, Vol. 37, No. 6, 01.06.1985, p. 674-679.

Research output: Contribution to journalArticle

Dominguez, RA, Goldstein, BJ, Jacobson, AF & Steinbook, RM 1985, 'Hypnotic efficacy of a modified triazolodiazepine, brotizolam', Clinical Pharmacology and Therapeutics, vol. 37, no. 6, pp. 674-679.
Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM. Hypnotic efficacy of a modified triazolodiazepine, brotizolam. Clinical Pharmacology and Therapeutics. 1985 Jun 1;37(6):674-679.
Dominguez, Roberto A. ; Goldstein, Burton J. ; Jacobson, Alan F. ; Steinbook, Richard M. / Hypnotic efficacy of a modified triazolodiazepine, brotizolam. In: Clinical Pharmacology and Therapeutics. 1985 ; Vol. 37, No. 6. pp. 674-679.
@article{420a8089160f40569378fc23e6f91158,
title = "Hypnotic efficacy of a modified triazolodiazepine, brotizolam",
abstract = "Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t 1 2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subjects who were receiving brotizolam were taking 0.50 mg. Results indicate brotizolam efficacy as measured by daily subject and weekly physician questionnaires in essentially all sleep parameters, including global subject and physician evaluation of treatment efficacy, sleep latency and sleep maintenance, and quality of sleep. Tolerance to the hypnotic action of brotizolam was not observed after 21 days of daily dosing.",
author = "Dominguez, {Roberto A.} and Goldstein, {Burton J.} and Jacobson, {Alan F.} and Steinbook, {Richard M.}",
year = "1985",
month = "6",
day = "1",
language = "English",
volume = "37",
pages = "674--679",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Hypnotic efficacy of a modified triazolodiazepine, brotizolam

AU - Dominguez, Roberto A.

AU - Goldstein, Burton J.

AU - Jacobson, Alan F.

AU - Steinbook, Richard M.

PY - 1985/6/1

Y1 - 1985/6/1

N2 - Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t 1 2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subjects who were receiving brotizolam were taking 0.50 mg. Results indicate brotizolam efficacy as measured by daily subject and weekly physician questionnaires in essentially all sleep parameters, including global subject and physician evaluation of treatment efficacy, sleep latency and sleep maintenance, and quality of sleep. Tolerance to the hypnotic action of brotizolam was not observed after 21 days of daily dosing.

AB - Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t 1 2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subjects who were receiving brotizolam were taking 0.50 mg. Results indicate brotizolam efficacy as measured by daily subject and weekly physician questionnaires in essentially all sleep parameters, including global subject and physician evaluation of treatment efficacy, sleep latency and sleep maintenance, and quality of sleep. Tolerance to the hypnotic action of brotizolam was not observed after 21 days of daily dosing.

UR - http://www.scopus.com/inward/record.url?scp=0021864091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021864091&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 674

EP - 679

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -